Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Dynavax (DVAX) Tops Q3 EPS by 14c; Offers FY23 Revenue Guidance
November 2, 2023 4:20 PM EDTDynavax (NASDAQ: DVAX) reported Q3 EPS of $0.10, $0.14 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $69.51 million versus the consensus estimate of $60.3 million.
GUIDANCE:
Dynavax sees FY2023 revenue of $210-220 million, versus the consensus of $224.7... More



